|
Volumn 17, Issue SUPPL. 1, 2012, Pages 12-15
|
Acute irreversible oxalate nephropathy in a lung transplant recipient treated successfully with a renal transplant
|
Author keywords
Cystic fibrosis; Hyperoxaluria; Lung transplant; Oxalate; Renal transplant
|
Indexed keywords
BASILIXIMAB;
CALCIUM CARBONATE;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID;
OXALIC ACID;
PREDNISOLONE;
TACROLIMUS;
ACUTE KIDNEY FAILURE;
ADULT;
ANTIBIOTIC THERAPY;
ARTICLE;
BLOOD TRANSFUSION;
CASE REPORT;
CYSTIC FIBROSIS;
DIALYSIS;
GLOMERULUS FILTRATION RATE;
GRAFT RECIPIENT;
HISTOPATHOLOGY;
HUMAN;
HYPEROXALURIA;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY BIOPSY;
KIDNEY DISEASE;
KIDNEY TRANSPLANTATION;
LUNG TRANSPLANTATION;
MALE;
OXALOBACTER FORMIGENES;
POSTOPERATIVE HEMORRHAGE;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
RISK FACTOR;
URINE LEVEL;
ADULT;
ANTI-INFECTIVE AGENTS;
BIOLOGICAL MARKERS;
BIOPSY;
CYSTIC FIBROSIS;
HUMANS;
HYPEROXALURIA;
ILEUM;
IMMUNOSUPPRESSIVE AGENTS;
INTESTINAL ABSORPTION;
KIDNEY DISEASES;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
LUNG TRANSPLANTATION;
MALE;
OXALATES;
OXALOBACTER FORMIGENES;
REOPERATION;
RISK FACTORS;
TREATMENT OUTCOME;
|
EID: 84859856432
PISSN: 13205358
EISSN: 14401797
Source Type: Journal
DOI: 10.1111/j.1440-1797.2012.01585.x Document Type: Article |
Times cited : (4)
|
References (2)
|